PERRIGO Co plc·4

Mar 10, 2:01 PM ET

Lockwood-Taylor Patrick 4

Research Summary

AI-generated summary

Updated

Perrigo (PRGO) CEO Patrick Lockwood‑Taylor Exercises Options, Receives Award

What Happened
Patrick Lockwood‑Taylor, CEO and Director of Perrigo Company plc (PRGO), reported derivative exercises and the vesting/settlement of restricted stock units on March 6, 2026. He acquired 11,727 shares via exercise (reported at $10.72 per share, $125,713) and received 13,839 shares as an award/vesting (reported at $10.72 per share, $148,354). To cover tax and/or exercise obligations, 9,243 shares were surrendered/withheld (4,240 shares valued at $45,453 and 5,003 shares valued at $53,632). The filing also reports a related derivative disposition of 11,727 shares recorded with N/A value (see Key Details).

Key Details

  • Transaction date: March 6, 2026; filing date: March 10, 2026 (filed 4 days after the transactions; Form 4s are typically due within two business days).
  • Reported prices/values: exercise and award reported at $10.72 per share. Total acquired (cash/award) ≈ 25,566 shares worth ~$274,067; total shares withheld/disposed for taxes ≈ 9,243 shares worth ~$99,085.
  • Shares owned after the transactions: not reported in the supplied data.
  • Footnotes of note:
    • F1: Vesting of performance‑based restricted stock units granted July 10, 2023.
    • F2–F4: Each restricted stock unit (RSU) represents a contingent right to receive one Perrigo ordinary share; one grant vests in two equal annual installments beginning March 6, 2026.
  • Transaction codes: M = option/derivative exercise; A = award/vesting; F = shares surrendered/withheld to satisfy tax/exercise obligations.

Context
The filing shows an exercise/settlement of derivative awards and vesting RSUs with shares withheld to satisfy tax obligations (a routine, cashless-like withholding). The separate M-line with 11,727 shares reported as disposed with N/A value appears tied to the derivative conversion/settlement reported the same day; the filing treats both the exercise/acquisition and the related derivative disposition. This activity reflects award vesting and exercise mechanics rather than an open‑market sale by the CEO.